Kinetics of Desensitization and Recovery from Desensitization for Human Alpha4beta2-nicotinic Acetylcholine Receptors Stably Expressed in SH-EP1 Cells
Overview
Authors
Affiliations
Aim: Studies were conducted to define the kinetics of the onset of and recovery from desensitization for human alpha4beta2-nicotinic acetylcholine receptors (nAChR) heterologously expressed in the SH-EP1 human epithelial cell line.
Methods: Whole-cell patch clamp recordings were performed to evaluate alpha4beta2-nAChR currents.
Results: Application of 0.1 micromol/L nicotine or 1 mmol/L acetylcholine (ACh) for 1 s or longer induced two phases, with time constants of approximately 70 and approximately 700 ms, for the onset of alpha4beta2-nAChR desensitization. For a given duration of agonist exposure, recovery from desensitization induced by nicotine was slower than recovery from ACh-induced desensitization. Comparisons with published reports indicate that time constants for the recovery of alpha4beta2-nAChRs from desensitization are smaller than those for the recovery of human muscle-type nAChRs(1) from desensitization produced by the same concentrations and durations of exposure to an agonist. Moreover, the extent of human alpha4beta2-nAChR desensitization and rate of recovery are the same, regardless of whether they are measured using whole-cell recording or based on published findings(2) using isotopic ion flux assays; this equality demonstrates the equivalent legitimacy of these techniques in the evaluation of nAChR desensitization. Perhaps most significantly, recovery from desensitization also was best fit to a biphasic process. Regardless of whether it was fit to single or double exponentials, however, half-times for recovery from desensitization grew progressively longer with an increased duration of agonist exposure during the desensitizing pulse.
Conclusion: These findings indicate the existence of alpha4beta2-nAChRs in many distinctive states of desensitization, as well as the induction of progressively deeper states of desensitization with the increased duration of agonist exposure.
Chen D, Gao F, Ma X, Brek Eaton J, Huang Y, Gao M Front Pharmacol. 2019; 10:72.
PMID: 30837868 PMC: 6383119. DOI: 10.3389/fphar.2019.00072.
Pauses in cholinergic interneuron firing exert an inhibitory control on striatal output in vivo.
Zucca S, Zucca A, Nakano T, Aoki S, Wickens J Elife. 2018; 7.
PMID: 29578407 PMC: 5869016. DOI: 10.7554/eLife.32510.
Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission.
Mamaligas A, Cai Y, Ford C Sci Rep. 2016; 6:37834.
PMID: 27886263 PMC: 5122907. DOI: 10.1038/srep37834.
Shen L, Cui W, Chen R, Wang H Acta Pharmacol Sin. 2016; 37(3):312-21.
PMID: 26806304 PMC: 4775840. DOI: 10.1038/aps.2015.106.
Wang J, Kuryatov A, Jin Z, Norleans J, Kamenecka T, Kenny P J Biol Chem. 2015; 290(48):28834-46.
PMID: 26432642 PMC: 4661399. DOI: 10.1074/jbc.M115.676551.